Baidu
map
FRONT MED-LAUSANNE 润色咨询

Frontiers in Medicine

出版年份:暂无数据 年文章数:5853 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2022-06-26 145f7fc8m73暂无昵称

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2022-10-24 ms9000001765004289

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:meta
    经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2022-12-05 ms1000001601271803 来自江苏省

    偏重的研究方向:肿瘤
    经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2022-12-22 William chen 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:针灸;内科;穴位按压
    经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。
    总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。
    2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。
    9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。
    11月5日另一个reviewer也同意了。
    然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。
    祝大家好运!

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2024-05-11 灵释 来自山东省

    审稿速度:2.0
    经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2023-09-11 ms6000000552773025 来自广西

    审稿速度:3.0 | 投稿命中率:95.0
    偏重的研究方向:呼吸
    经验分享:4.1投
    5.23一审返修
    6.22 二审返修
    7.12接收
    7.24 online

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2024-02-27 ms3000001258476343 来自黑龙江省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2023-12-18 P拾荒者 来自浙江省

    偏重的研究方向:内科
    经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2021-07-26 ms7000001962210336

    请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1228686, encodeId=d46712286867e, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:中科院预警期刊为啥还有人投?发在这种期刊是科研路上的一大污点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51135102179, createdName=145f7fc8m73暂无昵称, createdTime=Sun Jun 26 07:56:17 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095760, encodeId=d11d2095e6037, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:meta<br>经验分享:两个月接收 速度没的说 性价比高 研究生之友 接收后两天proof 已缴费两万多 不知何时能online 不知何时能被wos检索到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Mon Oct 24 10:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104384, encodeId=d4cd210438408, content=偏重的研究方向:肿瘤<br>经验分享:7.8投,11.28接收,审稿人和编辑比较宽容,但是看的很细,前前后后修改了四次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Mon Dec 05 12:35:23 CST 2022, time=2022-12-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107042, encodeId=106e210e0422f, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:针灸;内科;穴位按压<br>经验分享:我觉得自己的投稿经验有一定借鉴意义,分享给大家。<br>总体来说,杂志外审还是属于快的,而且我遇到的审稿专家是统计学家,及其仔细,对统计到了苛刻的程度,大小修总共修了4次才给通过。同时非常感谢他,经过这次审稿,自己的统计学知识得到了不少提高。<br>2022年6月14日投稿,很快就分配了AE。等了一个月,7月送外审。<br>9月底外审结束,IR激活,一个reviewer提了意见并直接同意发表,另一个给了大修,并反复修了4次。<br>11月5日另一个reviewer也同意了。<br>然后进入了漫长的review finalized阶段。这个阶段一般来说,如果AE到位,1-2周左右就可以FV,然后无意外就接受。我等了足足一个多月。后来打听到原来AE根本没接手我这个稿件,导致长时间停留在RF。一个月后editor变为了frontiers in medicine。过了10天左右,找到了另一个AE,editor变为编辑名字,编辑处理很快,2天就FV,然后12月22日接受了。<br>祝大家好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2991721013, createdName=William chen, createdTime=Thu Dec 22 11:42:08 CST 2022, time=2022-12-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2204177, encodeId=a17c22041e70c, content=审稿速度:2.0<br>经验分享:效率还是挺高的。2.22投稿。3.28回来三个审稿人的意见,一个小修,一个大修,一个拒绝,Interactive review forum 自动激活。4.7修回,给小修的审稿人接收。4.16给大修的审稿人又给了意见。4.17修回,给大修的审稿人给了接收。4.20第四个审稿人给了意见,让加了三篇作者一样的参考文献。当天修回,第四个审稿人给了接收。4.25AE给了一大堆语法和时态的意见。5.2修回,5.6 Article accepted for publication.同时收到邮件,问后来加的三篇参考文献是不是迫于压力加的,如果是可以直接删掉。目前在等proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4ef1679163, createdName=灵释, createdTime=Sat May 11 22:49:24 CST 2024, time=2024-05-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2157153, encodeId=777f215e153a5, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:呼吸<br>经验分享:4.1投<br>5.23一审返修<br>6.22 二审返修<br>7.12接收<br>7.24 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fbb8624288, createdName=ms6000000552773025, createdTime=Mon Sep 11 16:25:38 CST 2023, time=2023-09-11, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189778, encodeId=78042189e78af, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:1.16投,2.27接收,编辑比较宽容,审稿人看的非常细,修改了5次,但接手很痛快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a2c8207869, createdName=ms3000001258476343, createdTime=Tue Feb 27 23:32:57 CST 2024, time=2024-02-27, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2175575, encodeId=3fc221e557564, content=偏重的研究方向:内科<br>经验分享:审稿人1在11.7返修意见,审稿人2在12.2号返修意见。我们12.12上传返修稿及回复意见,12.14审稿人2同意发表,现在审稿人1还没发表意见,他会不会忘记了,后面该怎么搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Mon Dec 18 10:26:42 CST 2023, time=2023-12-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1002873, encodeId=231810028e3dd, content=请问Review is ongoing 消失2天后多出了一行You will be contacted as soon as the editor comments or reviewers' reports are ready.什么意思,是审稿结论有争议嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Mon Jul 26 22:56:24 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172620, encodeId=121721e262073, content=审稿速度:3.0<br>偏重的研究方向:肿瘤<br>经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Sun Dec 03 09:17:37 CST 2023, time=2023-12-03, status=1, ipAttribution=北京)]
    2023-12-03 烂医生 来自北京

    审稿速度:3.0
    偏重的研究方向:肿瘤
    经验分享:垃圾中的战斗机,非常慢,8个月了,一收一拒,正在邀请新的审稿人,很垃圾,千万别投浪费青春

    0

共234条页码: 1/24页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map